Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;14(3):1045-54.
doi: 10.1208/s12249-013-9993-6. Epub 2013 Jun 26.

Design and formulation technique of a novel drug delivery system for azithromycin and its anti-bacterial activity against Staphylococcus aureus

Affiliations

Design and formulation technique of a novel drug delivery system for azithromycin and its anti-bacterial activity against Staphylococcus aureus

M Joyce Nirmala et al. AAPS PharmSciTech. 2013 Sep.

Retraction in

Abstract

Azithromycin, an important member of the azalide subclass is effective against both Gram-positive and Gram-negative organisms. Certain physicochemical properties of the drug like poor water solubility and relatively low bioavailability of 37% due to incomplete absorption after ingestion, aroused the need for the development of a novel drug delivery system to enhance the solubilization potential and antibacterial activity against Staphylococcus aureus at a very low concentration. Cinnamon oil (Cinnamonum zeylanicum)-based microemulsion system formulated using non-ionic surfactant, Tween 20, and water was characterized. The drug-incorporated system F4 (oil to surfactant ratio of 1:4 (v/v)) showed enhanced solubilization of the drug, droplet diameter of 5-8 nm, and a good thermodynamic stability. The effect of surfactant concentration exhibited a negative correlation with droplet size diameter and turbidity and a positive correlation with stability and viscosity. The system was investigated for its antibacterial activity that demonstrated a significantly higher activity at a minimum concentration (4 μg/ml) of the novel drug-loaded system in comparison with the conventional formulation (128 μg/ml). Examination through scanning electron microscopy analysis further confirmed a considerable morphologic variation due to alteration in the membrane permeability of the microemulsion-treated system. The small droplet size of the microemulsion system and the antibacterial property of cinnamon oil, together, accounts clearly for the enhanced efficacy of the new formulated system F4 and not just azithromycin alone. Staining with acridine orange/ethidium bromide dyes as examined through fluorescence microscopy also substantiated with the results of membrane permeability of bacteria. Thus, our study discloses a potential oral drug delivery system of azithromycin with improved biocompatibility.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Droplet size distribution of drug-loaded cinnamon oil-based microemulsion (F4) as determined by DLS
Fig. 2
Fig. 2
The effect of surfactant concentration has a positive correlation on the viscosity of formulations F1 to F5
Fig. 3
Fig. 3
a Visual appearance of the formulations F1 to F5 (milky white to transparent). b The effect of surfactant concentration has a negative correlation on the turbidity of F1 to F5 formulations
Fig. 4
Fig. 4
Kinetic stability of the drug-loaded cinnamon oil microemulsion formulation (F4)
Fig. 5
Fig. 5
Comparison of alteration in membrane permeability of both conventional (test 1)- and microemulsion (test 2)-treated cells by the leakage of UV absorbing substances at 260 nm against S. aureus
Fig. 6
Fig. 6
Fluorescence micrograph of acridine orange/ethidium bromide-stained S. aureus cells. a Untreated (control) cells are green in color. b Conventional formulation of azithromycin-treated cells are also green in color at 4 μg/ml concentration. c Cinnamon oil microemulsion formulation-treated cells are red in color at the same concentration
Fig. 7
Fig. 7
Scanning electron microscopic images to identify the morphological changes of S. aureus-treated cells. a Treated cells with conventional formulation of azithromycin. b Treated cells with cinnamon oil microemulsion formulation of azithromycin showed significant morphological changes

References

    1. Crosseley KB, Archer GL. The staphylococci in human diseases. 1. New York: Livingstone; 1997.
    1. Ashley DJ, Brindle MJ. Penicillin resistance in staphylococci isolated in a casually department. J Clin Pathol. 1980;13:336–338. doi: 10.1136/jcp.13.4.336. - DOI - PMC - PubMed
    1. Dinos GP, Michelinaki M, Kalpaxis DL. Insights into the mechanism of azithromycin interaction with an Escherichia coli functional ribosomal complex. Mol Pharmacol. 2001;59(6):1441–1445. - PubMed
    1. Hoepelman IM, Schneider MME. Azithromycin; the first of the tissue-selective azalides. Int J Antimicrob Agents. 1995;5:145–167. doi: 10.1016/0924-8579(95)00009-W. - DOI - PubMed
    1. Mazzei T, Mini E, Novelli A, Periti P. Chemistry and mode of action of macrolides. J Antimicrob Chemother. 1993;31:1–9. doi: 10.1093/jac/31.suppl_C.1. - DOI - PubMed

Publication types

LinkOut - more resources